WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'5601 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 11'9041 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'385'567  1'377'065  1'368'440  1'359'821  1'351'248  1'280'429  1'165'429  984'016 
Births 18'440  18'455  18'375  18'204  17'945  16'111  26'447  21'018 
Surviving infants 18'203  18'203  18'108  17'920  17'648  15'719  25'601  20'184 
Pop. less than 5 years 90'187  88'934  87'400  85'579  84'172  83'372  136'835  98'790 
Pop. less than 15 years 249'829  247'738  246'604  246'707  248'516  327'734  341'465  348'344 
Female 15-49 years 372'548  375'435  377'356  378'179  378'186  347'573  306'018  232'603 

Number of reported case

(Click for retrospective incidence data for China)
Diphtheria 19  421  9'767 
Japanese encephalitis 2'178  1'763  1'625  2'541  3'913 
Measles 26'883  6'183  9'943  38'159  52'461  71'093  85'705  1'122'285 
Mumps 327'759  479'518  454'385  298'932  299'329 
Pertussis 1'712  2'183  2'517  1'764  1'612  5'561  20'015  613'648 
Polio* 21  5'065  7'442 
Rubella 17'580  40'156  65'549  43'117  69'860 
Rubella (CRS)
Tetanus (neonatal) 492  674  1'057  1'412  3'230 
Tetanus (total) 492 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for China)
Vaccine year result method % card seen                                                
BCG 2007  99  HHS     100  99  100  99  99  85  99 
DTP1          100  99  100  99  99 
DTP3 2007  91  HHS     100  99  100  99  99  85  97 
HepB_BD          99  96  95  92  93 
HepB3 2007  93  HHS     100  99  100  99  99  60 
Hib3         
JapEnc          100  99  99  99 
MCV 2007  92  HHS     100  99  100  99  99  98  98 
MCV2          100  99  99  99  98 
PCV1         
PCV3         
Pol3 2007  92  HHS     100  99  100  99  99  90  98 
Rota1         
Rota_last         
Rubella1          96  99  99  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for China)
BCG 99  99  99  99  99  84  99 
DTP1 99  99  99  99  99  94  98 
DTP3 99  99  99  99  99  85  97 
HepB3 99  99  99  99  99  60 
HepB_BD 96  96  95  92  93 
Hib3
MCV 99  99  99  99  99  84  98 
MCV2 99  99  99  99  98 
PnC3
Pol3 99  99  99  99  99  86  98 
Rota_last

Number of districts in the country 2'959  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 99
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTaP 3, 4, 5, 18 months; Yes
HepA 18 months; Yes
HepB birth; 1, 6 months; Yes
JapEnc 8 months; 2 years; No and M8, +D7, Y2, Y6 for the inactivated vaccine
MMR 18 months; Yes
MR 8 months; Yes
MenA 6-18 months; +3 months; Yes polysaccharide
MenAC 3, 6 years; Yes
OPV 2, 3, 4 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015       
Nº of districts with microplans that include activities to raise immunization coverage number           2'859  3'132 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 2'959  2'956  3'092  3'092  3'118  3'105  3'132 
Nº districts with DTP3 coverage >=80% number 2'952  2'955  3'048  3'038  3'093  3'094  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  99  98  99  100 
Nº districts with measles (MCV1) coverage >=95% number 2'917  2'913  3'002  2'983  2'812     
% of districts with MCV1 coverage >=95% From 0 to 100% 99  99  97  96  90     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100    100     

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.